Biomedical Patents
This POSTnote considers how patent law is applied to biomedical inventions and examines the potential impact on patient access to diagnostic tests and innovation.
Intellectual propertyMedical ethicsResearch and innovation
Briefing
In October 2011, the European Court of Justice banned patents for inventions involving stem cells derived from embryos. This case highlighted some of the challenges the patent system faces when assessing biomedical inventions. This POSTnote considers how patent law is applied to biomedical inventions and examines the potential impact on patient access to diagnostic tests and innovation.
Documents